ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MLS Medical Solutn

7.72
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Medical Solutn LSE:MLS London Ordinary Share GB0009739649 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 7.72 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Source BioScience PLC Holding(s) in Company (6798E)

05/11/2015 10:27am

UK Regulatory


TIDMSBS

RNS Number : 6798E

Source BioScience PLC

05 November 2015

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i) 
 
 
 1. Identity of the issuer or the        Source BioScience plc 
  underlying issuer of existing shares 
  to which voting rights are attached: 
  (ii) 
--------------------------------------  ---------------------- 
 
 
 2 Reason for the notification (please tick the appropriate box 
  or boxes): 
------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                             ü 
-----------------------------------------------------------------  ------------ 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already 
  issued to which voting rights are attached 
-----------------------------------------------------------------  ------------ 
 An acquisition or disposal of instruments with similar 
  economic effect to qualifying financial instruments 
-----------------------------------------------------------------  ------------ 
 An event changing the breakdown of voting rights 
-----------------------------------------------------------------  ------------ 
 Other (please 
  specify): 
-----------------  ----------------------------------------------  ------------ 
 
 
 
 3. Full name of person(s) subject     CHARIOT FUND - SPARTAN FUND LTD. 
  to the notification obligation:                 SAC CLASS B 
  (iii) 
------------------------------------  --------------------------------- 
 4. Full name of shareholder(s)        CHARIOT FUND - SPARTAN FUND LTD. 
  (if different from 3.): (iv)                    SAC CLASS B 
------------------------------------  --------------------------------- 
 5. Date of the transaction and                21 October 2015 
  date on which the threshold is 
  crossed or reached: (v) 
------------------------------------  --------------------------------- 
 6. Date on which issuer notified:             4 November 2015 
------------------------------------  --------------------------------- 
 7. Threshold(s) that is/are crossed               Over 3% 
  or 
  reached: (vi, vii) 
------------------------------------  --------------------------------- 
 
 
 8. Notified details: 
------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
------------------------------------------------------------------------------------------------- 
 Class/type      Situation previous        Resulting situation after the triggering 
  of              to the triggering         transaction 
  shares          transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
--------------  ------------------------  ------------------------------------------------------- 
                 Number       Number       Number       Number of voting        % of voting 
                  of           of           of shares    rights                  rights (x) 
                  Shares       Voting 
                               Rights 
--------------  -----------  -----------  -----------  ----------------------  ------------------ 
                                           Direct       Direct       Indirect   Direct   Indirect 
                                                         (xi)         (xii) 
--------------  -----------  -----------  -----------  -----------  ---------  -------  --------- 
 GB0009739649    16,021,429   16,021,429   17,491,429   17,491,429     N/A      5.01%    N/A 
--------------  -----------  -----------  -----------  -----------  ---------  -------  --------- 
 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------- 
 Type of financial   Expiration     Exercise/       Number of voting         % of voting 
  instrument          date (xiii)    Conversion      rights that              rights 
                                     Period (xiv)    may be 
                                                     acquired if 
                                                     the 
                                                     instrument is 
                                                     exercised/ converted. 
------------------  -------------  --------------  -----------------------  ------------ 
  N/A 
------------------  -------------  --------------  -----------------------  ------------ 
 
 
 C: Financial Instruments with similar economic effect to Qualifying 
  Financial Instruments (xv, xvi) 
----------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
----------------------------------------------------------------------------------------------- 
 Type of financial   Exercise   Expiration   Exercise/     Number of voting     % of voting 
  instrument          price      date         Conversion    rights instrument    rights (xix, 
                                 (xvii)       period        refers to            xx) 
                                              (xviii) 
------------------  ---------  -----------  ------------  -------------------  ---------------- 
 N/A                                                                            Nominal   Delta 
------------------  ---------  -----------  ------------  -------------------  --------  ------ 
 
 
 
 Total (A+B+C) 
------------------------------------------------------ 
 Number of voting rights   Percentage of voting rights 
------------------------  ---------------------------- 
  17,491,429                5.01% 
------------------------  ---------------------------- 
 
 
 9. Chain of controlled undertakings through which the voting rights and/or 
  the 
  financial instruments are effectively held, if applicable: (xxi) 
--------------------------------------------------------------------------- 
 
   N/A 
--------------------------------------------------------------------------- 
 
 
 Proxy Voting: 
------------------------------------------- 
 10. Name of the proxy holder:          N/A 
------------------------------------  ----- 
 11. Number of voting rights proxy      N/A 
  holder will cease to hold: 
------------------------------------  ----- 
 12. Date on which proxy holder will    N/A 
  cease to hold voting rights: 
------------------------------------  ----- 
 
 
 13. Additional information:      N/A 
------------------------------  ----- 
 14. Contact name:                N/A 
------------------------------  ----- 
 15. Contact telephone number:    N/A 
------------------------------  ----- 
 
 
 Note: Annex should only be submitted to the FCA not the issuer 
 Annex: Notification of major interests in share 
 
 A: Identity of the persons or legal entity subject to the notification 
  obligation 
-------------------------------------------------------------------------------- 
 Full name                             CHARIOT FUND, SPARTAN FUND LTD. 
  (including legal form of legal        SAC CLASS B 
  entities) 
------------------------------------  ------------------------------------------ 
 Contact address                       Equity Trust House, Caves Village 
  (registered office for legal          West Bay Street Nassau, Bahamas 
  entities)                             N-10697 
------------------------------------  ------------------------------------------ 
 Phone number & email                  +1 (242) 676-8188 
                                        mdean@equitybahamas.com 
------------------------------------  ------------------------------------------ 
 Other useful information              Michael Dean, Vice President Investment 
  (at least legal representative        Funds Services 
  for legal persons) 
------------------------------------  ------------------------------------------ 
 
 B: Identity of the notifier, if applicable 
-------------------------------------------------------------------------------- 
 Full name 
-------------------------------------------  ----------------------------------- 
 Contact address 
-------------------------------------------  ----------------------------------- 
 Phone number & email 
-------------------------------------------  ----------------------------------- 
 Other useful information 
  (e.g. functional relationship with 
  the person or legal entity subject 
  to the notification obligation) 
-------------------------------------------  ----------------------------------- 
 
 C: Additional information 
-------------------------------------------------------------------------------- 
 
 For notes on how to complete form TR-1 please see the FCA website. 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUGGWPGUPAGUA

(END) Dow Jones Newswires

November 05, 2015 05:27 ET (10:27 GMT)

1 Year Medical Solutions Chart

1 Year Medical Solutions Chart

1 Month Medical Solutions Chart

1 Month Medical Solutions Chart

Your Recent History

Delayed Upgrade Clock